國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

前瞻台灣生技製藥產業政策—結合德菲法與Q方法 = Policy Fore...

國立高雄大學亞太工商管理學系碩士班

前瞻台灣生技製藥產業政策—結合德菲法與Q方法 = Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology

紀錄類型:	書目-語言資料,印刷品 : 單行本
並列題名:	Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology
作者:	王郁倫,
其他團體作者:	國立高雄大學
出版地:	[高雄市]
出版者:	撰者;
出版年:	民100
面頁冊數:	139葉圖，表格 : 30公分;
標題:	台灣生技製藥產業
標題:	Delphi survey
電子資源:	http://handle.ncl.edu.tw/11296/ndltd/93647082589501446188
附註:	參考書目：葉94-99
附註:	內容為英文
其他題名:	前瞻臺灣生技製藥產業政策—結合德菲法與Q方法
摘要註:	台灣早在1980年代就將生物科技產業列為發展重點，行政院在2007年指出生技製藥產業為國家產業發展主軸之一，更於2009年推出「生技起飛鑽石方案」以活絡整個產業。生技製藥產業在面對未來的不確定時，更需要有全盤的前瞻計劃來做長期規劃。目前國內並無生技製藥產業前瞻相關研究，本研究希望藉由國外生技製藥前瞻2030年的相關文獻，找出台灣未來20年生技製藥產業能在國際上發光的立足點。因此本研究之研究問題有三：1. 未來20年，台灣生技製藥將會面臨什麼樣的機會與挑戰？2. 產官學研各界對於生技製藥產業是否存在認知差異？各利害關係人的政策偏好又是如何？3. 台灣政府應該如何前瞻未來台灣生技製藥產業？本研究蒐集了英國與美國的生技製藥產業前瞻計畫之文獻後，將其摘錄成130句語匯，接著再以競爭條件與生技製藥生產價值鏈構成的語句架構來做篩選，濃縮成為24句訪談敘述句。為了讓訪談敘述句更有權威、可靠性，本研究特別採用修正式的德菲法，在經過13位專家學者全程參與二輪之德菲問卷後，最後收斂成為24句訪談敘述句。本研究採用Q方法，其為結合質化與量化的研究方法。本研究利用24句收斂後訪談敘述句讓30位產、官、學、研各界專家進行Q排列與訪談。在經過PQMethod軟體分析後，本研究發現在未來20年台灣生技製藥產業應以四項為優先發展重點：間接支援政策、直接支援政策、投入更多資源在研發階段、以及跨界的共同合作。而間接與直接支援政策、投入更多資源在研發階段等機制更被各界視為政策優先。本研究發現為：各利害關係人存在認知落差、政府與產業界資訊不對稱、未來應增加研發資源投入、產業合作應多元跨域。本研究對於未來20年台灣生技製藥產業之建議為：1.政府應利用政策行銷手法來推廣產業政策，以減少認知落差，尤其是中小企業。2.政府應利用政策工具來配置政府資源，尤其是應該培育商業行銷人才以獲取更多國外投資。3.共同合作的部分有可以非常多元，包括跨科技、跨產業與跨區域的合作，有助於創新研發與拓展新市場。 Foresight programs in science and technology policy across Europe have been examined as responses from government to the changes and uncertainty in the future. The foresight studies have become a common tool to investigate what priorities should be set and how the resources will be allocated. However, there are not sufficient foresight researches on the biopharmaceutical industry in Taiwan. Although the cooperation of the government and stakeholders contribute enormously to the industry competition, there may be the existence of conceptualizing differentiation among them which results in inconsistency in policymaking and implementation. Therefore, this study aims to find out what the biopharmaceutical industry will be like in the next 20 years.Q methodology integrates qualitative and quantitative techniques to reveal social perspectives, and is often used to handle multi-view issues which are helpful for the interviewees to raise the real point of view on the research topic. This research aims at investigating officials’ and stakeholders’ patterns of cognitions toward policy foresight of biotechnology in Taiwan by using Q method. As mentioned above, biopharmaceutical industry is one of the main economical development objectives which were set by Taiwan government. This research aims to find out:1. What opportunities and challenges will Taiwan’s biopharmaceutical industry encounter in the next 20 years?2. Is there any existence of cognitive differences toward biopharmaceutical industry among the sectors of industry, government, academia, and research institution? And what are the policy preferences of the stakeholders?3. How does Taiwan government foresee the future of the bio-pharmaceutical industry in Taiwan? In this research, 130 statements were collected from varied literatures published by OECD, American and European government to form a concourse. At the same time, a factorial design was formulated for this research based on the industrial value chain and competitive conditions matrix to make 24 statements. The 24 statements which are based on an extensive review of the biopharmaceutical literature were applied to conduct the modified Delphi survey. After two rounds of Delphi survey, 24 modified or new statements will become 24 Q cards to exam 30 interviewees’ points of view. In the end, the consensus would be formed and the priorities would be set. Moreover, policy instruments will be applied to provide policy suggestions and resources will be allocated to the right place and in the right time in the future.After applying the Q methodology, I found out the policy priorities which come from the interviewees’ perspectives could be ordered and divided into four patterns: indirectly supported policy, directly supported policy, investment in R&D and collaboration. The main priorities for the biopharmaceutical industry in Taiwan are directly and indirectly supported policy and collaboration. The findings in this study are: cognition gap among stakeholders, uneven information between the government and the industry, increase R&D resource and investment, and collaboration with cross-field. This research suggested that the government should apply policy marketing strategies to bridge the cognition gaps and policy instrument to bridge the policy gaps. Meanwhile, policy instruments and policy marketing will be given to suggest how to distribute resources and bridge the cognition gap while Taiwan has the determination to cultivate the biopharmaceutical industry for next 20 years.The contributions of this study are to provide some directions for the government, which wants to cultivate the biopharmaceutical industry, to know the developing priorities, and then to allocate resources with limited budget.

前瞻台灣生技製藥產業政策—結合德菲法與Q方法 = Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology
王, 郁倫

前瞻台灣生技製藥產業政策—結合德菲法與Q方法 = Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology / 王郁倫撰 - [高雄市] : 撰者, 民100. - 139葉 ; 圖，表格 ; 30公分.
參考書目：葉94-99內容為英文.
台灣生技製藥產業Delphi survey

前瞻台灣生技製藥產業政策—結合德菲法與Q方法 = Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology
LDR:07496nam0a2200301 450 001 300307
005 20170214094147.0
009 300307
010 0 $b 精裝
010 0 $b 平裝
100 $a 20170214y2011 m y0chiy50 e
101 1 $a eng $d chi $d eng
102 $a tw
105 $a ak am 000yy
200 1 $a 前瞻台灣生技製藥產業政策—結合德菲法與Q方法 $d Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology $z eng $f 王郁倫撰
210 $a [高雄市] $c 撰者 $d 民100
215 0 $a 139葉 $c 圖，表格 $d 30公分
300 $a 參考書目：葉94-99
300 $a 內容為英文
314 $a 指導教授：李亭林博士
328 $a 碩士論文--國立高雄大學亞太工商管理學系碩士班
330 $a 台灣早在1980年代就將生物科技產業列為發展重點，行政院在2007年指出生技製藥產業為國家產業發展主軸之一，更於2009年推出「生技起飛鑽石方案」以活絡整個產業。生技製藥產業在面對未來的不確定時，更需要有全盤的前瞻計劃來做長期規劃。目前國內並無生技製藥產業前瞻相關研究，本研究希望藉由國外生技製藥前瞻2030年的相關文獻，找出台灣未來20年生技製藥產業能在國際上發光的立足點。因此本研究之研究問題有三：1. 未來20年，台灣生技製藥將會面臨什麼樣的機會與挑戰？2. 產官學研各界對於生技製藥產業是否存在認知差異？各利害關係人的政策偏好又是如何？3. 台灣政府應該如何前瞻未來台灣生技製藥產業？本研究蒐集了英國與美國的生技製藥產業前瞻計畫之文獻後，將其摘錄成130句語匯，接著再以競爭條件與生技製藥生產價值鏈構成的語句架構來做篩選，濃縮成為24句訪談敘述句。為了讓訪談敘述句更有權威、可靠性，本研究特別採用修正式的德菲法，在經過13位專家學者全程參與二輪之德菲問卷後，最後收斂成為24句訪談敘述句。本研究採用Q方法，其為結合質化與量化的研究方法。本研究利用24句收斂後訪談敘述句讓30位產、官、學、研各界專家進行Q排列與訪談。在經過PQMethod軟體分析後，本研究發現在未來20年台灣生技製藥產業應以四項為優先發展重點：間接支援政策、直接支援政策、投入更多資源在研發階段、以及跨界的共同合作。而間接與直接支援政策、投入更多資源在研發階段等機制更被各界視為政策優先。本研究發現為：各利害關係人存在認知落差、政府與產業界資訊不對稱、未來應增加研發資源投入、產業合作應多元跨域。本研究對於未來20年台灣生技製藥產業之建議為：1.政府應利用政策行銷手法來推廣產業政策，以減少認知落差，尤其是中小企業。2.政府應利用政策工具來配置政府資源，尤其是應該培育商業行銷人才以獲取更多國外投資。3.共同合作的部分有可以非常多元，包括跨科技、跨產業與跨區域的合作，有助於創新研發與拓展新市場。 Foresight programs in science and technology policy across Europe have been examined as responses from government to the changes and uncertainty in the future. The foresight studies have become a common tool to investigate what priorities should be set and how the resources will be allocated. However, there are not sufficient foresight researches on the biopharmaceutical industry in Taiwan. Although the cooperation of the government and stakeholders contribute enormously to the industry competition, there may be the existence of conceptualizing differentiation among them which results in inconsistency in policymaking and implementation. Therefore, this study aims to find out what the biopharmaceutical industry will be like in the next 20 years.Q methodology integrates qualitative and quantitative techniques to reveal social perspectives, and is often used to handle multi-view issues which are helpful for the interviewees to raise the real point of view on the research topic. This research aims at investigating officials’ and stakeholders’ patterns of cognitions toward policy foresight of biotechnology in Taiwan by using Q method. As mentioned above, biopharmaceutical industry is one of the main economical development objectives which were set by Taiwan government. This research aims to find out:1. What opportunities and challenges will Taiwan’s biopharmaceutical industry encounter in the next 20 years?2. Is there any existence of cognitive differences toward biopharmaceutical industry among the sectors of industry, government, academia, and research institution? And what are the policy preferences of the stakeholders?3. How does Taiwan government foresee the future of the bio-pharmaceutical industry in Taiwan? In this research, 130 statements were collected from varied literatures published by OECD, American and European government to form a concourse. At the same time, a factorial design was formulated for this research based on the industrial value chain and competitive conditions matrix to make 24 statements. The 24 statements which are based on an extensive review of the biopharmaceutical literature were applied to conduct the modified Delphi survey. After two rounds of Delphi survey, 24 modified or new statements will become 24 Q cards to exam 30 interviewees’ points of view. In the end, the consensus would be formed and the priorities would be set. Moreover, policy instruments will be applied to provide policy suggestions and resources will be allocated to the right place and in the right time in the future.After applying the Q methodology, I found out the policy priorities which come from the interviewees’ perspectives could be ordered and divided into four patterns: indirectly supported policy, directly supported policy, investment in R&D and collaboration. The main priorities for the biopharmaceutical industry in Taiwan are directly and indirectly supported policy and collaboration. The findings in this study are: cognition gap among stakeholders, uneven information between the government and the industry, increase R&D resource and investment, and collaboration with cross-field. This research suggested that the government should apply policy marketing strategies to bridge the cognition gaps and policy instrument to bridge the policy gaps. Meanwhile, policy instruments and policy marketing will be given to suggest how to distribute resources and bridge the cognition gap while Taiwan has the determination to cultivate the biopharmaceutical industry for next 20 years.The contributions of this study are to provide some directions for the government, which wants to cultivate the biopharmaceutical industry, to know the developing priorities, and then to allocate resources with limited budget.
510 1 $a Policy Foresight into Taiwan Biopharmaceutical Industry:A Combination of Delphi and Q Methodology $z eng
517 1 $a 前瞻臺灣生技製藥產業政策—結合德菲法與Q方法 $z chi
610 0 $a 台灣生技製藥產業 $a 前瞻 $a 產業政策 $a 德菲法 $a Q方法
610 1 $a Delphi survey $a Public policy $a Taiwan biopharmaceutical industry $a Foresight $a Q methodology
681 $a 008M/0019 $b 343425 1042 $v 2007年版
700 1 $a 王 $b 郁倫 $4 撰 $3 518717
712 0 2 $a 國立高雄大學 $b 亞太工商管理學系碩士班 $3 166023
801 0 $a tw $b NUK $c 20111019 $g CCR
856 7 $z 電子資源 $2 http $u http://handle.ncl.edu.tw/11296/ndltd/93647082589501446188